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As we previously reported1•2 documentation of pan-
creas rejection remains problematic because of the 
lack of specific and sensitive markers. Since most pancreas 
transplants are performed simultaneous with a kidney, 
clinical dysfunction from rejection, documented by an in-
crease in serum creatinine and renal-core biopsy, automat-
ically leads to the treatment of both grafts. Rejections of 
pancreatic grafts are in some way preemptively treated by 
the initiation of kidney-transplant treatment. Nevertheless, 
in combined kidney-pancreas transplantation, an incidence 
of isolated pancreas rejection has been documented.3 .4 We 
report herein our experience in documenting rejection 
episodes with fine-needle aspiration biopsy (FNAB) in 
pancreas transplant patients. 
The FNAB rationale resides in the fact that the immu-
noactivation phenomenon begins in the graft. where infil-
trating mononuclear cells endure a transformation process 
into "blasts." Acute cellular rejection is defined by an 
accumulation of immature cells (lymphoblasts. plasma-
blasts. monoblasts) that can be quantified according to 
established cytologic criteria. Vascular rejection is generally 
assigned to humoral immunity with the proliferation of 
mononuclcar phagocytcs and tissue macrophages. How-
ever, on several occasions the cellular and humoral compo-
nent of rejcction can be simultaneously detected. 
MATERIALS AND METHODS 
Between July 1994 and July 19%. a totaillf n pancreas transplants 
were performed at the University of Pittsburgh in rype [ diabetic 
patients. Sixty-two patients received a simultaneous kidney trans-
plant (SPK). tive patients received a sequential pancreas'( PAK), 
and live patients received a solitary pancreas \ PTA). 
Immunosuppression consisted of taerolimus (0.05 mg;kg IV for 3 
to n days followed hy 0.15 mglkg p.o. hid). azathioprine (5 mg;kg IV 
followed Iw 1.5 to 2.0 mg;kg p.o.), or mycophenolate mofctil (I g 
p.o. bid. if tolerated) and steroids. No antilymphocyte antihody 
infusion \ induction therapy) was emplowd. Rejection episodes 
WCfe trealed With methylpredmsolone holuses. OKTJ monoclonal 
:mtihodies were used only in four patients and A TGAM in two 
,)thers. 
CMV prophvlaxis was no! llsed <:\ccpt in Ihe scm-positive tll 
,ero-nc1,!:I!i\'c donor-reCIpient comhinatilllls \ 15 pallents lor during 
. ,nll· r CL'II trcalll1ent. 
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To avoid the high complication rate related to bladder drainage,' 
enteric drainage was performed in most (54) of the patients. 6 
FNABs of both grafts were performed as previously described,,7 
according to an established protocol and when clinically indicated. 
RESULTS 
In this series of patients there was no mortality. The kidney 
and pancreas survival was 95% and 86%, respectively. 
In the SPK group, 40 patients presented one or more 
rejection episodes. In the majority of cases, they were 
documented with FNAB. In 25 cases, FNAB evidenced 
rejection in both grafts, whereas in five cases, FNAB 
showed isolated rejection of the pancreas. One patient lost 
both organs from antibody-mediated rejection and another 
one rejected both grafts following discontinuation of immu-
nosuppression because of severe systemic candida infection, 
Two PTA patients lost the graft (one patient because of 
persistent active rejection despite OKT3 treatment and one 
other because of reflux pancreatitis). 
No grafts were lost in the P AK group despite every 
patient-presented rejection episode, detected by FNAB 
without other clinical symptoms of pancreatic dysfunction. 
CONCLUSIONS 
FNAB of the pancreas transplant has been proven to be a 
reliable technique for monitoring rejection episodes that 
otherwise could have heen overlooked with the usual 
biochemical markers. No complications (bleeding, fistula. 
infections) have heen reported in our series of patients who 
underwent repeated FNABs. 
The enteric-drained patient group had significantly lower 
rates of surgical complications in comparison with the 
hladder-drained group. The fact that we could easily per-
form FNAB in ~nteric-drain~d pancreata has permitted a 
timely uiagnosis of rejection and might have optimized the 
amount of immunosuppression. thus avoiding infections 
and further complications. 
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